Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

APC/C-Cdh1-targeted substrates as potential therapies for Alzheimer’s disease

  • Lapresa, Rebeca
  • Agulla, Jesús
  • Bolaños, Juan P.
  • Almeida, Angeles
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and the main cause of dementia in the elderly. The disease has a high impact on individuals and their families and represents a growing public health and socio-economic burden. Despite this, there is no effective treatment options to cure or modify the disease progression, highlighting the need to identify new therapeutic targets. Synapse dysfunction and loss are early pathological features of Alzheimer’s disease, correlate with cognitive decline and proceed with neuronal death. In the last years, the E3 ubiquitin ligase anaphase promoting complex/cyclosome (APC/C) has emerged as a key regulator of synaptic plasticity and neuronal survival. To this end, the ligase binds Cdh1, its main activator in the brain. However, inactivation of the anaphase promoting complex/cyclosome-Cdh1 complex triggers dendrite disruption, synapse loss and neurodegeneration, leading to memory and learning impairment. Interestingly, oligomerized amyloid-β (Aβ) peptide, which is involved in Alzheimer’s disease onset and progression, induces Cdh1 phosphorylation leading to anaphase promoting complex/cyclosome-Cdh1 complex disassembly and inactivation. This causes the aberrant accumulation of several anaphase promoting complex/cyclosome-Cdh1 targets in the damaged areas of Alzheimer’s disease brains, including Rock2 and Cyclin B1. Here we review the function of anaphase promoting complex/cyclosome-Cdh1 dysregulation in the pathogenesis of Alzheimer’s disease, paying particular attention in the neurotoxicity induced by its molecular targets. Understanding the role of anaphase promoting complex/cyclosome-Cdh1-targeted substrates in Alzheimer’s disease may be useful in the development of new effective disease-modifying treatments for this neurological disorder., AA is funded by The Instituto de Salud Carlos III (PI21/00727, co-funded by the European Union). JB is funded by Agencia Estatal de Investigación (PID2019-105699RBI00). The Institute of Functional Biology and Genomics is funded by the Junta de Castilla y León (CLU-2017-03 co-funded by the P.O. FEDER CyL 14-20; CL-EI-2021-08, co-funded by the European Union ERDF). RL and JA are funded by Junta de Castilla y León (CSI151P20).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Control nucleocitoplasmático del complejo Calpaína- 2/Calpastatina durante la tolerancia isquémica neuronal

  • Hermosín Montes, J. M.
Trabajo presentado para lograr el título de Doctor por la Universidad de Salamanca, Departamento de Bioquímica y Biología Molecular, Programa de Doctorado en Biología Funcional y Genómica, La homeostasis celular se mantiene gracias a los sistemas de control de la síntesis y degradación de proteínas, como son el sistema ubiquitina-proteasoma, el de autofagia-lisosomal y las proteasas. En este sentido, las proteasas no lisosomales, conocidas como calpaínas, constituyen un sistema complejo de modulación de la función proteica durante el desarrollo de numerosas patologías, incluidas las neurológicas, como es la isquemia. Junto a la excitotoxicidad, la entrada intracelular de calcio, el control en la estabilidad proteica y la generación de especies reactivas de oxígeno, la activación de las calpaínas es un factor clave implicado en la muerte neuronal inducida por la cascada isquémica. Por tanto, las estrategias neuroprotectoras encaminadas a la interrupción de los mecanismos que desencadenan este fenómeno y, en concreto, el sistema de las calpaínas puede tener una importante relevancia en la resistencia frente al daño isquémico. Nosotros pensamos que el precondicionamiento isquémico, una conocida herramienta de neuroprotección endógena, podría estar implicado en la regulación del sistema de las calpaínas y por lo tanto en la respuesta de tolerancia isquémica neuronal. Con estos antecedentes, y puesto de manifiesto la importancia que posee el control de la estabilización de las proteínas durante la isquemia, en la presente Tesis Doctoral nos hemos propuesto identificar la función de las calpaínas durante la tolerancia neuronal en respuesta al daño isquémico., Este trabajo ha sido financiado con proyectos de investigación concedidos por el Instituto de Salud Carlos III (CP0014/00010, PI18/00103, PI21/00727 y RD21/0006/0005, co-financiados por la Unión Europea) y la Junta de Castilla y León (CSI151P20; Escalera de Excelencia CLU 2017-03 cofinanciada por la Unión Europea FEDER/FSE+ and NextGenerationEU). Jesús Hermosín obtuvo un contrato predoctoral de personal investigador de la Junta de Castilla y León (EDU/556/2019).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Missense Variant in TP53 Could Be a Genetic Biomarker Associated with Bone Tissue Alterations

  • Usategui-Martín, Ricardo
  • Galindo-Cabello, Nadia
  • Pastor-Idoate, Salvador
  • Fernández-Gómez, José María
  • Del Real, Álvaro
  • Ferreño, Diego
  • Lapresa, Rebeca
  • Martín-Rodriguez, Francisco
  • Riancho, José A.
  • Almeida, Angeles
  • Pérez-Castrillón, José Luis
Metabolic bone diseases cover a broad spectrum of disorders that share alterations in bone metabolism that lead to a defective skeleton, which is associated with increasing morbidity, disability, and mortality. There is a close connection between the etiology of metabolic bone diseases and genetic factors, with TP53 being one of the genes associated therewith. The single nucleotide polymorphism (SNP) Arg72Pro of TP53 is a genetic factor associated with several pathologies, including cancer, stroke, and osteoporosis. Here, we aim to analyze the influence of the TP53 Arg72Pro SNP on bone mass in humanized Tp53 Arg72Pro knock-in mice. This work reports on the influence of the TP53 Arg72Pro polymorphism in bone microarchitecture, OPG expression, and apoptosis bone status. The results show that the proline variant of the TP53 Arg72Pro polymorphism (Pro72-p53) is associated with deteriorated bone tissue, lower OPG/RANK ratio, and lower apoptosis in bone tissue. In conclusion, the TP53 Arg72Pro polymorphism modulates bone microarchitecture and may be a genetic biomarker that can be used to identify individuals with an increased risk of suffering metabolic bone alterations., This research was funded by Ministerio de Ciencia e Innovación (Spain Government; PID2020-114585RA-I00 to RUM and SPI) and Instituto de Salud Carlos III (Spain; PI21/00727 to AA)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Blood Progenitor Cell Mobilization Driven by TWEAK Promotes Neovascularization and Reduces Brain Damage in a Rat Model of Intracerebral Hemorrhage

  • Romaus-Sanjurjo, Daniel
  • López-Arias, Esteban
  • Rodríguez González, Cristina
  • Hervella, Pablo
  • Rodríguez-Arrizabalaga, Mariña
  • Debasa-Mouce, Manuel
  • Pías-Peleteiro, Juan Manuel
  • Iglesias-Rey, Ramón
  • Aguiar, Pablo
  • Almeida, Ángeles
  • Castillo, José
  • Ouro, Alberto
  • Sobrino, Tomás
Non-traumatic intracerebral hemorrhage (ICH) is one of the most devastating and disabling forms of stroke; however, there are no effective pharmacological therapies available following the insult. Angiogenesis appears as a key step to overcoming the damage and promoting functional recovery. In this context, endothelial progenitor cells (EPCs) mobilization improves oxidative stress and promotes neovascularization, which has been linked to beneficial outcomes following both ischemic and hemorrhagic stroke. The TNF-like weak inducer of apoptosis (TWEAK), binding to its receptor Fn14, has been suggested as an inducer of EPCs differentiation, viability and migration to the injury site in a model of myocardial infarction. Here, we have performed a proof-of-concept preclinical study in a rat model of ICH where we report that a 50 μg/kg dose of rat recombinant TWEAK (rTWEAK) promotes blood progenitor cells mobilization, mainly EPCs. As soon as 72 h post-injury, brain neovascularization, and, importantly, long-term hematoma reduction and improved functional recovery is reported. In contrast, a higher dose of 150 μg/kg blocked those beneficial outcomes. Therefore, a low dose of rTWEAK treatment promotes neovascularization and reduces brain damage in a rat model of ICH. Further clinical studies will be needed to demonstrate if rTWEAK could represent a new strategy to promote recovery following ICH., This study was partially supported by grants from the Xunta de Galicia (IN607A2022/07), Instituto de Salud Carlos III (ISCIII) (PI22/00938; PI21/00727; RD21/0006/0005) and CIBERNED (CB22/05/00067). This project has also received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement (No. 101066444). R. Iglesias-Rey from the Miguel Servet Program of Instituto de Salud Carlos III and co-financed by the EU (CP22/00061). Furthermore, this study was also supported by grants from the INTERREG Atlantic Area (EAPA_791/2018_NEUROATLANTIC project), INTER-REG V A España Portugal (POCTEP) (0624_2IQBIONEURO_6_E), and the European Regional Development Fund (ERDF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Endogenous mitochondrial hydrogen peroxide regulates neurogenesis during cortical development

  • Mengual, Regina
  • Bobo-Jiménez, Verónica
  • Rodríguez González, Cristina
  • Lapresa, Rebeca
  • García-Rodríguez, Darío
  • Jiménez-Blasco, Daniel
  • Cabiscol, Elisa
  • Ros, Joaquim
  • Delgado-Esteban, María
  • Bolaños, Juan P.
  • Almeida, Ángeles
Reactive oxygen species (ROS), particularly superoxide anion (O2•-) and hydrogen peroxide (H2O2), originating from mitochondria, are increasingly recognized as critical mediators of physiological signaling and cellular function. While in the adult brain, mitochondrial ROS, specifically mitochondrial H2O2, modulate metabolism and sustains cognitive processes, their role in the developing cerebral cortex remains undefined. Here, we leverage a knock-in mouse model constitutively expressing mitochondrially targeted catalase (mCAT) to attenuate mitochondrial H2O2 levels and investigate their impact during cortical development. In neurosphere cultures derived from embryonic day 14.5 (E14.5) mCAT mice, reduced mitochondrial H2O2 altered glutathione redox homeostasis and glucose metabolism leading to suppressed progenitor cell proliferation, without compromising viability. In vivo, neural progenitor cell (NPC) proliferation, neuronal differentiation and cortical layering were disrupted starting at gestational day E15. Together, these data uncover a physiological role for mitochondrial hydrogen peroxide in orchestrating neural precursor proliferation and differentiation, ultimately influencing mammalian cerebral cortex formation., This work was funded by Instituto de Salud Carlos III, co-funded by the European Union, (PI21/00727, PI24/00810, RD24/0009/0005 to AA; CB16/10/00282 to JPB), and funded by the European Union - NextGeneration EU, Recovery and Resilience Facility (RD21/0006/0005, PMP22/00084 to AA), Junta de Castilla y León (CSI011P23 and Escalera de Excelencia CLU-2017-03 to AA and JPB), Agencia Estatal de Investigación (MICIU) (PID2022-138813OB-I00 and FEDER, UE to JPB; RED2022-134407-T to AA), and la Caixa Foundation (grant agreement LCF/PR/HR23/52430016 to JPB), the European Union's Horizon Europe research and innovation program under the MSCA Doctoral Networks 2021 (101072759; FuEl ThEbRaiN In healtThY aging and age-related diseases, ETERNITY, to A.A. and J.P.B.), and the European Research Council (ERC) Advanced Grant NeuroSTARS (ref. 101199747, to J.P.B.), Peer reviewed